Scalper1 News
Edwards Lifesciences stock jumped 5% in midday trading on the stock market today, following FDA approval late Monday of its latest artificial heart valve, Sapien XT. Edwards’ (EW)Sapien XT is a transcatheter aortic valve, the updated version of the original Sapien launched in 2011. The FDA approved it for patients who are inoperable or at high risk of death from traditional open-heart surgery. The news came just days after Sapien’s arch-rival, Scalper1 News
Scalper1 News